Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2019	06-2019	03-2019	12-2018	09-2018
Assets
Current Assets
Cash & Cash Equivalents	58,922	90,034	65,269	73,256	45,132
Marketable Securities	150,110	151,858	205,719	102,556	163,260
Receivables	5,000	N/A	N/A	27,000	N/A
TOTAL	$220,568	$249,905	$277,116	$207,922	$215,884

Non-Current Assets
PPE Net	14,917	15,263	15,378	14,449	13,493
Other Non-Current Assets	30,327	30,724	31,981	3,977	3,674
TOTAL	$45,244	$45,987	$47,359	$18,426	$17,167

Total Assets	$265,812	$295,892	$324,475	$226,348	$233,051

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	6,902	7,966	4,486	8,434	7,341
Accrued Expenses	18,694	14,737	13,521	14,948	15,718
TOTAL	$34,154	$44,696	$34,070	$31,970	$31,808

Non-Current Liabilities
Deferred Revenues	5,241	18,825	13,054	8,588	8,749
Other Non-Current Liabilities	29,670	30,485	31,362	2,753	2,763
TOTAL	$80,377	$62,654	$69,302	$48,756	$19,145

Total Liabilities	$114,531	$107,350	$103,372	$80,726	$50,953

Shareholders' Equity
Shares Outstanding, K	45,108	44,103	44,007	44,029	36,988
Common Shares	44	44	44	37	37
Retained earnings	-798,878	-757,469	-720,079	-684,775	-644,158
Other shareholders' equity	42	116	70	-8	-133
TOTAL	$151,281	$188,542	$221,103	$145,622	$182,098

Total Liabilities And Equity	$265,812	$295,892	$324,475	$226,348	$233,051